Paloma Partners Management CO Iovance Biotherapeutics, Inc. Transaction History

Paloma Partners Management CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$28.67 - $52.59 $307,829 - $564,658	-10,737 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$28.04 - $50.26 $1.36 Million - $2.43 Million	-48,334 Reduced 81.82%	10,737 $499,000
Q3 2020 Nov 16, 2020	SELL	$27.75 - $36.3 $3.45 Million - $4.51 Million	-124,146 Reduced 67.76%	59,071 $1.94 Million
Q2 2020 Aug 14, 2020	BUY	$27.21 - $41.0 $4.99 Million - $7.51 Million	183,217 New	183,217 $5.03 Million

319

243M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $923M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.